What is the purpose of this trial?
The purpose of this trial is to assess the efficacy and safety of E7777 (improved purity ONTAK) in patients with persistent and recurrent cutaneous T-cell lymphoma. A lead-in dose-finding part will be used to determine the dose of E7777 that should be used to test efficacy and safety.
Ages: 18 years and older
Dates: 07/19/2017 - 06/30/2019
Last Updated: 07/20/2017
Study HIC#: 2000020362